Total Payments
$2,781
2024 Payments
$16.26
Companies
37
Transactions
126
Medicare Patients
1,455
Medicare Billing
$85,015
Payment Breakdown by Category
Food & Beverage$2,631 (94.6%)
Education$149.99 (5.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,631 | 123 | 94.6% |
| Education | $149.99 | 3 | 5.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $579.17 | 16 | $0 (2023) |
| ABBVIE INC. | $559.27 | 32 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $238.70 | 13 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $169.70 | 3 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $159.64 | 5 | $0 (2022) |
| PFIZER INC. | $146.99 | 8 | $0 (2023) |
| Astellas Pharma US Inc | $129.10 | 3 | $0 (2022) |
| Biohaven Pharmaceutical Holding Company Ltd. | $70.48 | 3 | $0 (2022) |
| Sumitomo Pharma America, Inc. | $50.73 | 3 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $50.65 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $16.26 | 1 | Boston Scientific Corporation ($16.26) |
| 2023 | $906.06 | 51 | ABBVIE INC. ($312.00) |
| 2022 | $1,293 | 56 | Novo Nordisk Inc ($286.86) |
| 2021 | $565.02 | 18 | Novo Nordisk Inc ($144.25) |
All Payment Transactions
126 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/29/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 12/18/2023 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $3.88 | General |
| Category: NEUROSCIENCE | ||||||
| 11/29/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: Obesity | ||||||
| 11/09/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $124.70 | General |
| Category: NEUROSCIENCE | ||||||
| 11/08/2023 | Currax Pharmaceuticals LLC | NEXLETOL (Drug) | Education | In-kind items and services | $25.00 | General |
| Category: Cholesterol Reducer | ||||||
| 10/11/2023 | Currax Pharmaceuticals LLC | NEXLETOL (Drug) | Education | In-kind items and services | $25.00 | General |
| Category: Cholesterol Reducer | ||||||
| 09/13/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: Oncology | ||||||
| 09/06/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: PAIN | ||||||
| 09/01/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: NEUROSCIENCE | ||||||
| 08/23/2023 | Novo Nordisk Inc | Saxenda (Drug), Wegovy | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: Obesity | ||||||
| 08/17/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: RESPIRATORY | ||||||
| 08/16/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: PSYCHIATRY | ||||||
| 08/10/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $3.88 | General |
| Category: NEUROSCIENCE | ||||||
| 08/03/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: PAIN | ||||||
| 08/03/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: RESPIRATORY | ||||||
| 07/26/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $2.91 | General |
| Category: NEUROSCIENCE | ||||||
| 07/20/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: Diabetes | ||||||
| 07/14/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $2.84 | General |
| Category: NEUROSCIENCE | ||||||
| 07/13/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/12/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: NEUROSCIENCE | ||||||
| 07/06/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.91 | General |
| Category: NEUROSCIENCE | ||||||
| 06/28/2023 | PFIZER INC. | COMIRNATY (Biological), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: VACCINES | ||||||
| 06/15/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: Diabetes | ||||||
| 06/07/2023 | Supernus Pharmaceuticals, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 06/05/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 514 | 739 | $116,450 | $23,131 |
| 2022 | 14 | 632 | 930 | $184,833 | $38,460 |
| 2021 | 7 | 309 | 353 | $94,847 | $23,424 |
Total Patients
1,455
Total Services
2,022
Medicare Billing
$85,015
Procedure Codes
33
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 186 | 232 | $49,270 | $10,242 | 20.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 91 | 100 | $30,927 | $5,674 | 18.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 41 | 41 | $20,208 | $4,055 | 20.1% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 22 | 22 | $4,403 | $1,106 | 25.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 11 | 11 | $2,772 | $791.23 | 28.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 14 | 14 | $1,387 | $398.16 | 28.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 13 | 14 | $1,786 | $385.88 | 21.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 37 | 45 | $4,459 | $281.62 | 6.3% |
| 81003 | Automated urinalysis test | Office | 2023 | 44 | 49 | $674.73 | $107.80 | 16.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 16 | 16 | $251.36 | $54.56 | 21.7% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 20 | 80 | $251.20 | $24.58 | 9.8% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 19 | 115 | $60.95 | $9.16 | 15.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 209 | 315 | $66,897 | $14,900 | 22.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 120 | 156 | $48,246 | $9,904 | 20.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 67 | 67 | $33,024 | $6,938 | 21.0% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 27 | 28 | $8,167 | $1,963 | 24.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 21 | 21 | $9,818 | $1,165 | 11.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 15 | 15 | $4,570 | $848.23 | 18.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 27 | 28 | $2,775 | $760.75 | 27.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 25 | 28 | $3,572 | $711.62 | 19.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 35 | 53 | $3,978 | $409.69 | 10.3% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 12 | 24 | $1,788 | $391.58 | 21.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 11 | 11 | $1,139 | $301.40 | 26.5% |
| 81002 | Urinalysis, manual test | Office | 2022 | 36 | 40 | $628.40 | $137.16 | 21.8% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2022 | 13 | 60 | $188.40 | $23.84 | 12.7% |
About Meredith Bratcher, PA
Meredith Bratcher, PA is a Physician Assistant healthcare provider based in Murfreesboro, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/15/2020. The National Provider Identifier (NPI) number assigned to this provider is 1497357305.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Meredith Bratcher, PA has received a total of $2,781 in payments from pharmaceutical and medical device companies, with $16.26 received in 2024. These payments were reported across 126 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($2,631).
As a Medicare-enrolled provider, Bratcher has provided services to 1,455 Medicare beneficiaries, totaling 2,022 services with total Medicare billing of $85,015. Data is available for 3 years (2021–2023), covering 33 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Murfreesboro, TN
- Active Since 11/15/2020
- Last Updated 06/06/2023
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1497357305
Products in Payments
- VRAYLAR (Drug) $219.36
- Rybelsus (Drug) $215.49
- ENTRESTO (Drug) $201.50
- UBRELVY (Drug) $171.90
- XARELTO (Drug) $145.39
- RYBELSUS (Drug) $138.69
- NURTEC ODT (Drug) $124.43
- QULIPTA (Drug) $117.32
- ELIQUIS (Drug) $72.62
- Ozempic (Drug) $68.00
- GEMTESA (Drug) $66.30
- NEXLETOL (Drug) $50.00
- VYVANSE (Drug) $44.22
- Dayvigo (Drug) $39.45
- COMIRNATY (Biological) $38.72
- LEQVIO (Drug) $37.20
- Wegovy (Drug) $36.20
- JARDIANCE (Drug) $35.70
- TRELEGY ELLIPTA (Drug) $34.05
- Omnipod (Device) $32.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Murfreesboro
Joseph Ayers, Pa-C, PA-C
Physician Assistant — Payments: $41,218
Physician Assistant $41,218
Bailey Chitwood, Pa-C, PA-C
Physician Assistant — Payments: $17,989
Physician Assistant $17,989
Ruchi Patel, Pa, PA
Physician Assistant — Payments: $16,839
Physician Assistant $16,839
Taylor Copeland, Pa-C, PA-C
Physician Assistant — Payments: $11,795
Physician Assistant $11,795
Mr. Kurt Knoll, Pa-C, PA-C
Physician Assistant — Payments: $7,129
Physician Assistant $7,129
Jill Welker, Pa, PA
Physician Assistant — Payments: $6,426
Physician Assistant $6,426